Pacira BioSciences, Inc. (PCRX) analyst actions

PCRX analyst actions moved a median of -0.01% by the close. Rating and price-target actions on PCRX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the PCRX overview →

12 measured PCRX analyst action events.

Where these PCRX analyst actions landedvs 12 measured PCRX analyst action reactions
PCRX analyst actionMiddle 50% · -0.81% to +1.18%Zero: 0.00%Median: -0.01%Median -0.01%-1.50%0+1.50%
Middle 50% of PCRX analyst action reactions-0.81% to +1.18%
Median reaction (to close)-0.01%
Measured reactions12
Point-in-time · zero look-ahead

Half of the 12 PCRX analyst action events with a measured close landed between -0.81% and +1.18%; 50% closed up.

DateHeadlineEvent5-minTo close
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRX) And Encourages Stockholders to Reach OutPress release+0.18%+1.21%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRX) And Encourages Shareholders to Reach OutPress release-0.23%+2.25%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRX) And Encourages Shareholders to Reach OutPress release+0.14%-1.93%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRX) And Encourages Stockholders to Reach OutPress release-0.68%+0.94%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRX) And Encourages Shareholders to Reach OutPress release+0.63%-6.18%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRX) And Encourages Shareholders to Reach OutPress release+0.43%-0.17%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRX) And Encourages Stockholders to Reach OutPress release+0.57%+3.08%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRX) And Encourages Shareholders to Reach OutPress release+0.05%-0.14%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRX) And Encourages Stockholders to Reach OutPress release+0.04%-0.69%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Bronstein, Gewirtz & Grossman, LLC (PCRX) And Encourages Shareholders to Reach OutPress release+0.04%-1.16%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Bronstein, Gewirtz & Grossman, LLC (PCRX) And Encourages Stockholders to Reach OutPress release-0.96%+1.17%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRX) And Encourages Stockholders to Reach OutPress release+0.08%+0.12%
That’s how PCRX usually reacts to analyst actions — get an email when it moves on news →
Keep exploring

More PCRX: earnings → · SEC filings → · PCRX overview →

Other Healthcare names and their analyst actions

TickerEventsMedian 30-min% positive
Epizyme, Inc. (EPZM)1,145+0.04%51%
Neogen Corporation (NEOG)1,1430.00%48%
Anthem, Inc. (ANTM)1,140-0.01%49%
EXPRESS SCRIPTS (ESRX)1,137+0.02%51%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.